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1. Introduction
  Rickettsiosis occurs worldwide and continues to cause 
severe illness and death in healthy adults and children [1]. 
These diseases are caused by obligate intracellular 
bacteria belonging to the order Rickettsiales[2]. According 
comparisons of 16SrRNA gene (rrs) sequences, most 
pathogenic agents of the order Rickettsiales have been 
divided into two families, namely Rickettsiaceae and 
Anaplasmatacease. Extensive historical etiological, 
molecular and serological evidences demonstrates that 
typhus, spotted fever, scrub typhus, anaplasmoses, 
ehrlichioses, Q fever and bartonelloses cause human 
diseases in China. Although these diseases occur 
nationwide, only a limited number of laboratory-confirmed 
cases have been reported. Nearly all cases of rickettsoses 
are diagnosed based on the clinical features or are 
retrospectively diagnosed by laboratory detection. The 
Weil-Felix test, a very old laboratory diagnostic method that 
has been replaced by better tests in developed countries 
many years ago, is still the only available test in a few 
hospitals in China. Some emerging rickettsioses , such as 
anaplasmoses, ehrichioses and bartonelloses, are under 
recognized because of limited epidemiological, clinical 
and microbiological information commonly resulting in 
misdiagnoses and delays in treatment. 
  In 2006, an unusual cluster of nosocomial human-
to-human transmission of human anaplasmosis was 
demonstrated in Anhui Province[3]. Subsequently, 
serosurveys for  r icket ts iae including Anaplasma 
phagocytophilum (A. phagocytophilum) , Coxiella burnetii 
(C. burnetii) , Bartonella henselae(B. henselae) and Rickettsia 
typhi(R. typhi) in rural communities of Tianjin city, China 
were conducted and the average seroprevalences were 
8.8%,9.6%,6.4% and 4.1% for A. phagocytophilum, C. burnetii, 
B. henselae, and R. typhi, respectively[4]. Between 2007 and 
2009, a further serosurveys for rickettsiae in farmers and 
domestic animals were conducted in Jiangsu, Zhejiang, 
Shandong, Henan, Yunnan, Anhui, Xinjiang,Tianjin 
and Beijing Province/City, which revealed that positive 
tests were detected in all these places with the highest 
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positive rate of A. phagocytophilum (46.8%) in human in 
Hainan Province. As a result of these events, the Ministry 
of Health issued Guideline for Prevent and Control of 
Human Anaplamosis’ in February 2008[5]. Following this 
policy and with the support of the China-U.S. collaborative 
program on emerging and re-emerging infectious diseases 
(No. 1U2GGH000018-01), Epidemiology and laboratory 
training for anaplasmosis and related rickettsial diseases 
were held in Beijing from April 12, 2008 to April 20, 2008. 
Fifty eight epidemiologists and 10 laboratory technicians 
from 26 Provincial/City CDCs participated in the theoretical 
training. Because proper diagnostic testing for rickettsiae 
is lacking in most Provincial/City CDCs laboratories,faster 
and specific PCR diagnostic methods for rickettsiae and 
modern serological diagnostic testing for most members of 
the order rickettsiae were offered for training at provincial 
CDC laboratories.Ten technicians from 10 Provincial/City 
CDCs took part in the laboratory training course and joined 
in the external quality activities for detection of rickettsioses 
organized by the Department of Rickettsiology, National 
Institute of Communicable Disease Control and Prevention, 
China CDC. Herein, we report the results of the external 
quality control activities.
2. Materials and methods
2.1. Experimental design
  Like many viral infectious diseases, the general 
diagnostic methods for rickettsioses include detecting 
specific antibodies in patients’ serum by various methods 
including immunofluorescent assay (IFA)[6,7] and amplifying 
selected rickettsial genes in patients’ blood by PCR. We 
have developed an EQA program for the evaluation of 
the serological antibody test for A. phagocytophilum, R. 
heilongjiangensis and O. tsutsugamshi type Karp and one 
nested PCR amplifying of groEL genes for most members 
of the family Rickettsiaceae[8] and another nested PCR 
amplifying of 16SrRNA genes for the diagnosis of A. 
phagocytophilum and E. chaffeensis[9].
  Altogether 10 Provincial/City CDC laboratories joined the 
EQA program. The 10 laboratories were randomly named as 
L1, L2, L3, L4, L5, L6, L7, L8, L9 and L10. Each participating 
laboratory was requested to return their results within eight 
weeks.
2.2. Serological testing
  Each laboratory received a package containing serological 
testing materials including three slices of S1, S2 and 
S3 antigen of representative A. phagocytophilum, R. 
heilongjiangensis (SFG rickettsia) and O. tsutsugamshi 
type Karp respectively and 0.5 mL of S1’, S2’ and S3’ 
serum samples. Among these materials, S1 antigen slices 
and S1’ reference serum were provided by the Johns 
Hopkins University School of Medicine, USA and the S2 
and S3 antigens were prepared by L929 cell culture for R. 
heilongjiangensis and O. tsutsugamshi according to the 
previously described methods[6]. S2’ and S3’ reference sera 
were collected from patients with R. heilongjiangensis and 
O. tsutsugamshi respectively and then tested three times 
by three individual laboratory technicians, each time three 
parallel duplicates were conducted. Based on these results, 
we calculated the reference average antibody titer of R. 
heilongjiangensis and O. tsutsugamshi respectively. All 
materials were packed in a box containing ice and posted 
by air, with a warranty to be delivered within 24 hours. The 
experiments were performed as previously described[7]. 
We created criteria for the evaluation of the final report of 
results as good ( = reference titer), sufficient (＞ or ＜ one 
dilution of reference titer), and not acceptable(＞ or ＜ two 
dilutions of reference).
2.3. PCR Testing 
2.3.1. Primers
  Each laboratory received 12 vials containing six pairs of 
primers for the two set nested PCR[8,9], one was composed 
of Gro1-Gro2, SF-SR, and TF-TR primer pairs and the 
other included Out1-Out2, HGA1-HGA2, and HME1-HME2. 
Each vial contained 1OD primer powder, which is diluted 
to optimal concentration before use.  The primer sequences 
were as follows:
Primer Gro-1: 5’- AAGAAGGA/CGTGATAAC-3
Primer Gro-2: 5’- ACTTCA/CGTAGCACC-3’
Primer SF: 5′-ATAGAAGAAAAGCAATGATG-3′
Primer SR: 5′-CAGCTATTTGAGATTTAATTTG-3′
Primer TF: 5′-ATATATCACAGTACTTTGCAAC-3′
Primer TR: 5′-GTTCCTAACTTAGATGTATCAT-3′
Primer Out1: 5′-TTG AGA GTT TGA TCC TGG CTC AGA ACG-3′
Primer Out2: 5′-CAC CTC TAC ACT AGG AAT TCC GCTATC-3′
Primer HGA1: 5′-GTC GAA CGG ATT ATT CTT TAT AGC TTG -3′
Primer HGA2: 5′-TAT AGG TAC CGT CAT TAT CTT CCC TAT-3′
Primer HME1: 5′-CAA TTG CTT ATA ACC TTT TGG TTA TAA AT-3′
Primer HME2: 5′-TAT AGG TAC CGT CAT TAT CTT CCC TAT-3′
2.3.2. Reference plasmid DNA
  Each laboratory received 100 毺L of P1, P2, P3, P4 and 
P5 reference DNA with a concentration of 1010 copies /毺L. 
Reference DNA were designed and prepared as follows: 
In order to prepare P1 and P2, 649bp fragments were 
amplified from R. typhi W strain (TG rickettsiae) DNA and 
R. heilongjiangensis(SFG rickettsiae) DNA by PCR using 
Gro1 and Gro2 primers.  PCR products were purified 
and cloned into PGM-T cloning vectors. We selected 
positive clones and purified the recombinant plasmid. 
The plasmids were sequenced respectively to confirm the 
presence of the expected sequence from R. typhi W and 
R. heilongjiangensis. The concentration of the plasmid 
solution was quantified using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, 
Delaware); and then the concentration was adjusted to 1伊1010 
copies/毺L by calculating the weight of a single copy of a 
plasmid. Briefly, the weight of one recombinant plasmid was 
calculated by multiplying the size by the average mass of a 
DNA base pair (615 Da) and then multiplying the number by 
the weight of one atomic mass unit (1.67伊10-24 g)[9] .A serial 
10-fold dilution from 1010 to 100 copies/毺L was made and 
used to determine the LOD . To give a general estimation on 
the LOD for each laboratory, we created a qualitative ranking 
list to categorize the final results as excellent (100-102copy/
毺L), good (103-104 copy /毺L), sufficient (105-106copy/毺L) 
and unacceptable ( ≥107copy/毺L).
2.3.3. Action
  Participants used the reference DNAs as PCR templates to 
determine the quality and quantity of DNA according to the 
PCR amplifying conditions previously described[8,9].  They 
used the primers provided by the organizer and all their own 
equipment and laboratory supplies such as PCR reagents 
including Taq polymerase, deoxynucleotide triphosphates, 
and other reagents commonly used in their own laboratories, 
and PCR cycler and imaging systems. 
2.3.4. Stability
  In order to evaluate the reproducibility of the PCR assay, 
each laboratory was requested to perform triplicate per 
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  The etiological laboratory diagnosis of rickettsioses is 
very important because atypical clinical presentations 
and manifestation of rickettsial diseases often lead to 
misdiagnoses and delays in treatment resulting in multi-
organ involvement and even death. Timely diagnosis 
and etiologically directed treatments are crucial for the 
effective and rapid management of the disease to prevent 
the development of multi-organ failure and even death. The 
current gold standard for the diagnosis of rickettsial disease 
is IFA for specific antibodies of rickettsiae.  However, IFA 
requires two serum samples, one acute and one later, which 
does not allow for early diagnosis. PCR amplification is a 
great improvement, offering extensive possibilities for the 
detection and identification of rickettsiae during the early 
course of illness[10]. 
  In this study, we have designed and produced a reagent set 
suitable for the external assessment of immunofluorescent 
assay and nested PCR detecting targeted genes for diagnoses 
of rickettsial diseases. These were based on a training 
specimen per run per day for 3 days.
3. Results
  Nine of the 10 laboratories submitted complete results. The 
laboratory that did not provide results did not explain the 
reasons clearly.
3.1. Serological testing
  The numerical results provided by each laboratory were 
compared with the reference value of the specific antibody 
titer (1:64). On the basis of the evaluation criteria, eight 
of the nine submitted results were evaluated as good or 
sufficient while the last one was poor for S3 reference serum 
(antibody titer 1:2)(Table 1 and Figure 1). 
3.2. PCR testing 
3.2.1. Specificity
  All nine laboratories gave the expected bands of PCR 
using the P1, P2, P3, P4 and P5 reference DNA as templates. 
Negative controls were also good for each reference DNA 
for each laboratory. Three laboratories presented weak 
nonspecific bands when they nested amplified P1 and P2 
reference templates using primers of Gro1-Gro2 and SF-SR. 
3.2.2. Lowest limit of detection (LOD)
  LOD analysis confirmed wide variability of (105-1copy/毺L) 
among the laboratories. For the results of P1 reference 
DNA, 7 of 9 (78%) laboratories were excellent and 2 (22%) 
were good. For the results of P2 reference DNA, 1 of 9 (11%) 
laboratories was excellent, 6 (67%) were good and 2 (22%) 
were sufficient. For P3 the results of reference DNA, 7 of 9 
(78%) laboratories were excellent and 2 (22%) were good. 
As for the P4 reference DNA, 3 of 9 (33%) laboratories had 
excellent results, 5 (56%) were good and one laboratory’s 
results was unacceptable (107copy/毺L). For P5 reference 
DNA, 3 of 9 (33%) laboratories were excellent, 5 (55%) were 
good and one laboratory’s results was sufficient. Detailed 
evaluation of amplifying P1, P2, P3, P4 and P5 reference DNA 
are shown in Table 2. 
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Figure 1. Measurement of antibody for S1, S2 and S3 reference serum
3.2.3. Repeatability
  Repeatability varied in individual laboratories. However, 
the within-run deviations of each reference DNA each 
laboratories was within 10 copies/毺L, and total deviations 
within 100 copies/毺L.
4. Discussion
Table 1
Evaluation Results for serological testing.
Reference serum
  Laboratories Score
L1 L2 L3 L4 L5 L6 L7 L8 L9 Good sufficient unacceptable
S1 1:128 1:64 1:128 1:128 1:128 1:128 1:128 1:64 1:64 2 7 0
S2 1:32 1:32 1:128 1:64 1:32 1:32 1:64 1:128 1:64 3 6 0
S3 1:128 1:32 1:2 1:64 1:64 1:64 1:64 1:64 1:64 6 2 1
Note: L1-L9: represent 9 laboratories from 7 provincial CDC and two city level CDC. 
Table 2
Evaluation results of nine laboratories for PCR testing of P1, P2, P3, P4 and P5 reference DNA.
Reference
DNA
No. of laboratory Score
L1 L2 L3 L4 L5 L6 L7 L8 L9 Excellent good sufficient unacceptable
P1 102 103 102  103 100 102 10 10 102 7 2 0 0
P2 105 104 103  102 103 105  103  104 104 1 6 2 0
P3 102 104 103  107 100 102 10  102 102 7 2 0 0
P4 102 104 103 10 100 102 10  102 102 3 5 0 1
P5 104 103 103  106 100 102  104 10 104 3 5 1 0
Note: L1-L9: represent 9 laboratories from 7 provincial CDC and two city level CDC; Score criteria: excellent:100-102copy/毺L; good:103-104 
copy /毺L; sufficient :105-106copy/毺L); and unacceptable ( ≥107copy/毺L).
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workshop for the laboratory diagnostics of rickettsial diseases.
  With the serological data presented in this study, eight of 
the nine laboratories that submitted antibody titer results 
met the criteria, one failed. We determined  that the most 
common causes for inaccurate results were: (a) making 
serial dilutions of reference serum poorly, a process in 
which accurate pipetting is the key factor determining 
variability; (b) selecting carefully the most optimal working 
concentration of fluorescent labeled antibodies, a task 
that should be completed through pre-experiments; (c) 
problems with an aging mercury lamp in a fluorescence 
microscope, resulting in minor errors when performing IFA; 
and (d) reading errors made by individual technicians when 
observing the results under the fluorescence microscope .  
  The lowest limits of PCR testing for P1, P2, P3, P4 and P5 
reference DNA. had wider varieties than expected. For P3 
reference DNA, the minimum detecting DNA copy numbers 
from the nine laboratories ranged 1 copy/毺L to 107 copy/毺L. 
This huge difference most likely reflects varying quality 
across the different laboratories. The most likely causes 
of this problem include: (a) errors in serial dilutions of 
the reference DNA due to pipetting errors;(b) the amount 
of taking the original samples; (c) the activity of the Taq 
polymerase used in the PCR test may not have been the 
same all the time resulting in variable results; and (d) the 
types and properties of fluorochrome used in preparing the 
electrophoresis could contribute to variability.
  The sensitivity of molecular biologic methods for direct 
detection of rickettsiae is extremely important when there 
are relatively few bacteria in the clinical sample. In this 
study, the observed sensitivity varied significantly between 
laboratories. We believe the difference in observed 
sensitivity is caused by differences of work quality in these 
laboratories; adjusting and optimizing laboratory conditions 
for every participant laboratory should be emphasized 
in order to ensure the timely and accurate diagnosis of 
rickettsial infections in the future. At the same time, it is 
clear that a more comprehensive evaluation scheme that 
includes assessments of such systems as the DNA extraction 
procedure, which is the key step in PCR identification of 
rickettisae in various clinical samples, could be included in 
any future EQA scheme.    
  EQA is now regarded as an indispensable aspect of 
laboratory management and has been implemented 
successfully by a wide variety of laboratories across the 
EU [11-14]. In China, EQA has been conducted in clinical 
laboratories with limited laboratory procedures[15,16]. As 
we know, this is the first attempt of EQA for rickettisae 
surveillance system in China to ensure high quality work in 
the technically challenging field for laboratory diagnose that 
is needed for infectious disease surveillance. More and more 
laboratories in surveillance units should get certification 
through laboratory proficiency tests.
  The significance of the study is that training in a modern 
serological and rapid molecular diagnostic method of 
rickettsiae was popularized in 10 provincial CDC in China. 
In order to ensure the quality of a laboratory’s diagnostic 
testing for rickettsiae, EQA projects was first conducted and 
evaluated. Faster and specific PCR diagnostic methods for 
most members of the order rickettsiae were established and 
modern serological diagnostic testing (IFA) has replaced 
the traditional Weil Felix method in 10 provincial CDC 
laboratories in China.
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